XML 18 R8.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (101,215) $ (110,228)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation 29,960 30,632
Equity Securities, FV-NI, Gain (Loss) (2,900) (2,418)
Deferred tax expense (benefit) (1,007) 1,797
Stock-based compensation 54,618 60,370
Amortization of acquired intangible assets 24,101 23,311
Impairment of long-lived and indefinite-lived assets 6,251 4,446
Gain (Loss) On Contingent Consideration From Disposition Of Asset 0 268
Remeasurement of contingent consideration liabilities 8,287 5,603
Non-cash lease expense 6,753 7,052
Other Noncash Income (Expense) 2,001 229
Changes in assets and liabilities:    
Accounts receivable, net (30,072) (37,536)
Inventory, net (14,175) (1,065)
Increase (Decrease) in Operating Lease Liability (6,575) (6,603)
Accounts payable and accrued liabilities 58,633 (53,515)
Other assets 3,837 6,586
Other liabilities (5,814) (2,904)
Net cash provided by (used in) operating activities 30,809 (82,311)
Cash flows from investing activities:    
Purchases of marketable securities (80,315) (177,325)
Maturities and sales of marketable securities 77,557 43,978
Purchases of property, plant and equipment (31,174) (37,649)
Other investing activities (505) (442)
Net cash used in investing activities (34,437) (171,438)
Cash flows from financing activities:    
Repayments of Convertible Debt (249,172) 0
Payment, Tax Withholding, Share-Based Payment Arrangement (422) (1,408)
Other financing activities (6,577) (1,594)
Net cash used in financing activities (256,171) (3,002)
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 347,127 347,487
Restricted cash — included in other long-term assets, net 0 4,297
Total cash, cash equivalents and restricted cash 347,127 351,784
Supplemental disclosure of cash flow information:    
Interest paid 9,473 10,789
Supplemental disclosure of non-cash investing and financing activities    
Issuance of common stock to fund the Company's 401(k) match 43,943 40,550
Property, plant and equipment acquired but not paid 17,523 17,654
Cash, cash equivalents and restricted cash, end of period 347,127 351,784
Cash, cash equivalents and restricted cash, beginning of period 606,636 609,675
Net decrease in cash, cash equivalents and restricted cash (259,509) (257,891)
Effects of exchange rate changes on cash and cash equivalents $ 290 $ (1,140)